Drägerwerk AG & Co. KGaA (DRW8) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Drägerwerk AG & Co. KGaA (DRW8) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€74.80 Million ≈ $87.45 Million USD) by net assets (€1.51 Billion ≈ $1.76 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Drägerwerk AG & Co. KGaA to measure how much of total assets are equity-financed.
Drägerwerk AG & Co. KGaA - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Drägerwerk AG & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Drägerwerk AG & Co. KGaA (DRW8) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Drägerwerk AG & Co. KGaA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Drägerwerk AG & Co. KGaA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangzhou Guangri Stock Co Ltd
SHG:600894
|
0.021x |
|
Gubra A/S
CO:GUBRA
|
-0.519x |
|
Beijing Topnew Info And Tech Co Ltd
SHE:300895
|
0.032x |
|
Sinar Mas Agro Resources and Technology Tbk PT
JK:SMAR
|
0.103x |
|
Sitronix Technology Corp
TW:8016
|
0.064x |
|
Metals X Ltd
AU:MLX
|
0.134x |
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SHE:300401
|
0.021x |
|
Malakoff Corporation Bhd
KLSE:5264
|
0.021x |
Annual Cash Flow Conversion Efficiency for Drägerwerk AG & Co. KGaA (2005–2024)
The table below shows the annual cash flow conversion efficiency of Drägerwerk AG & Co. KGaA from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see Drägerwerk AG & Co. KGaA (DRW8) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €1.54 Billion ≈ $1.80 Billion |
€167.31 Million ≈ $195.60 Million |
0.109x | -19.11% |
| 2023-12-31 | €1.41 Billion ≈ $1.65 Billion |
€189.68 Million ≈ $221.75 Million |
0.135x | +223.13% |
| 2022-12-31 | €1.32 Billion ≈ $1.54 Billion |
€-144.23 Million ≈ $-168.62 Million |
-0.109x | -135.80% |
| 2021-12-31 | €1.26 Billion ≈ $1.47 Billion |
€384.89 Million ≈ $449.97 Million |
0.305x | -31.37% |
| 2020-12-31 | €1.03 Billion ≈ $1.21 Billion |
€459.98 Million ≈ $537.76 Million |
0.445x | +191.27% |
| 2019-12-31 | €1.08 Billion ≈ $1.26 Billion |
€164.42 Million ≈ $192.22 Million |
0.153x | +3936.11% |
| 2018-12-31 | €1.08 Billion ≈ $1.26 Billion |
€4.09 Million ≈ $4.78 Million |
0.004x | -97.18% |
| 2017-12-31 | €1.07 Billion ≈ $1.25 Billion |
€143.34 Million ≈ $167.57 Million |
0.134x | -31.07% |
| 2016-12-31 | €1.00 Billion ≈ $1.17 Billion |
€195.32 Million ≈ $228.35 Million |
0.195x | +361.89% |
| 2015-12-31 | €945.93 Million ≈ $1.11 Billion |
€39.86 Million ≈ $46.60 Million |
0.042x | -79.90% |
| 2014-12-31 | €896.61 Million ≈ $1.05 Billion |
€187.98 Million ≈ $219.77 Million |
0.210x | +150.33% |
| 2013-12-31 | €815.97 Million ≈ $953.95 Million |
€68.34 Million ≈ $79.90 Million |
0.084x | -65.54% |
| 2012-12-31 | €727.20 Million ≈ $850.17 Million |
€176.75 Million ≈ $206.64 Million |
0.243x | +10.90% |
| 2011-12-31 | €729.62 Million ≈ $853.00 Million |
€159.91 Million ≈ $186.95 Million |
0.219x | -36.34% |
| 2010-12-31 | €636.56 Million ≈ $744.21 Million |
€219.14 Million ≈ $256.20 Million |
0.344x | -29.92% |
| 2009-12-31 | €393.82 Million ≈ $460.42 Million |
€193.45 Million ≈ $226.17 Million |
0.491x | +160.88% |
| 2008-12-31 | €517.64 Million ≈ $605.18 Million |
€97.47 Million ≈ $113.95 Million |
0.188x | -39.66% |
| 2007-12-31 | €505.49 Million ≈ $590.97 Million |
€157.75 Million ≈ $184.42 Million |
0.312x | +88.90% |
| 2006-12-31 | €539.99 Million ≈ $631.31 Million |
€89.21 Million ≈ $104.29 Million |
0.165x | +41.12% |
| 2005-12-31 | €257.68 Million ≈ $301.25 Million |
€30.16 Million ≈ $35.27 Million |
0.117x | -- |
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more